Literature DB >> 2345301

Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis.

A C Steere1, V P Berardi, K E Weeks, E L Logigian, R Ackermann.   

Abstract

The intrathecal antibody response to Borrelia burgdorferi was evaluated in American and West German patients with Lyme neuroborreliosis. By an antibody capture enzyme immunoassay, 12 (92%) of 13 patients from the USA with Lyme meningitis were found to have intrathecal antibody production to B. burgdorferi, usually of multiple isotypes, most commonly IgA. Of 12 patients with putative late central nervous system manifestations of Lyme disease, 5 (42%) had local production of IgG or IgA spirochetal antibody, but cerebrospinal fluid (CSF) abnormalities could not be demonstrated in 6 patients with late peripheral nervous system manifestations of the disorder. Compared with American patients, 30 European patients with neuroborreliosis had significantly higher CSF:serum ratios of specific antibody both early and late in the illness. Intrathecal antibody determinations are the most specific diagnostic test currently available for Lyme neuroborreliosis, but local antibody production in CSF is an inconsistent finding in American patients with late neurologic manifestations of the disorder.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2345301     DOI: 10.1093/infdis/161.6.1203

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

Review 1.  Overdiagnosis and overtreatment of Lyme neuroborreliosis are preventable.

Authors:  A Prasad; D Sankar
Journal:  Postgrad Med J       Date:  1999-11       Impact factor: 2.401

2.  Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease.

Authors:  S E Schutzer; P K Coyle; L B Krupp; Z Deng; A L Belman; R Dattwyler; B J Luft
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

3.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

Review 4.  Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections.

Authors:  Juan Carlos Garcia-Monco; Jorge L Benach
Journal:  Ann Neurol       Date:  2019-01       Impact factor: 10.422

5.  Utilization of tests for Lyme disease antibody at a university hospital.

Authors:  I Nachamkin; D L Riddle; M Feldman; P H Edelstein
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

Review 6.  Laboratory diagnosis of Lyme disease: advances and challenges.

Authors:  Adriana R Marques
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

Review 7.  Lyme borreliosis.

Authors:  Allen C Steere; Franc Strle; Gary P Wormser; Linden T Hu; John A Branda; Joppe W R Hovius; Xin Li; Paul S Mead
Journal:  Nat Rev Dis Primers       Date:  2016-12-15       Impact factor: 52.329

8.  Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient.

Authors:  Joseph L Gugliotta; Heidi K Goethert; Victor P Berardi; Sam R Telford
Journal:  N Engl J Med       Date:  2013-01-17       Impact factor: 91.245

9.  Evaluation of the polymerase chain reaction for the detection of Borrelia burgdorferi in cerebrospinal fluid of children with acute peripheral facial palsy.

Authors:  H J Christen; H Eiffert; A Ohlenbusch; F Hanefeld
Journal:  Eur J Pediatr       Date:  1995-05       Impact factor: 3.183

10.  Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients.

Authors:  R Kaiser
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.